Skip to content
10-Q/A

Quarterly Report

NUNZIA PHARMACEUTICAL COMPANY

0001683168-22-002051

← back to feed
Filed
Mar 29, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Mar 29, 2022 434.12M sh
Operating Cash Flow restated Q3 2021 · Sep 30, 2021 $484
Operating Cash Flow Q3 2021 · Sep 30, 2020 $0
Long Term Debt Q3 2021 · Sep 30, 2021 $23K
Long Term Debt Q3 2021 · Dec 31, 2020 $23K
Stockholders Equity restated Q3 2021 · Sep 30, 2021 −$111.21K
Stockholders Equity restated Q3 2021 · Dec 31, 2020 −$59.4K
Current Liabilities Q3 2021 · Sep 30, 2021 $97.69K
Current Liabilities Q3 2021 · Dec 31, 2020 $36.4K
Total Liabilities Q3 2021 · Sep 30, 2021 $120.69K
Total Liabilities Q3 2021 · Dec 31, 2020 $59.4K
Current Assets Q3 2021 · Sep 30, 2021 $4.48K
Current Assets Q3 2021 · Dec 31, 2020 $0
Total Assets Q3 2021 · Sep 30, 2021 $9.48K
Total Assets Q3 2021 · Dec 31, 2020 $0
Eps Basic Q3 2021 · Sep 30, 2021 $0.00
Eps Basic Q3 2021 · Sep 30, 2021 $0.00
Eps Basic Q3 2021 · Sep 30, 2020 $0.00
Eps Basic Q3 2021 · Sep 30, 2020 $0.00
Sga Expense restated Q3 2021 · Sep 30, 2021 $34.53K
Sga Expense restated Q3 2021 · Sep 30, 2021 $56.8K
Sga Expense Q3 2021 · Sep 30, 2020 $6.98K
Sga Expense Q3 2021 · Sep 30, 2020 $15.22K
Net Income restated Q3 2021 · Sep 30, 2021 −$34.53K
Net Income restated Q3 2021 · Sep 30, 2021 −$56.8K
Net Income Q3 2021 · Jun 30, 2021 −$6.63K
Net Income Q3 2021 · Mar 31, 2021 −$15.65K
Net Income Q3 2021 · Sep 30, 2020 −$6.98K
Net Income Q3 2021 · Sep 30, 2020 −$15.22K
Net Income Q3 2021 · Jun 30, 2020 −$1.34K
Net Income Q3 2021 · Mar 31, 2020 −$6.9K
Operating Income restated Q3 2021 · Sep 30, 2021 −$34.53K
Operating Income restated Q3 2021 · Sep 30, 2021 −$56.8K
Operating Income Q3 2021 · Sep 30, 2020 −$6.98K
Operating Income Q3 2021 · Sep 30, 2020 −$15.22K
Revenue Q3 2021 · Sep 30, 2021 $0
Revenue Q3 2021 · Sep 30, 2021 $0
Revenue Q3 2021 · Sep 30, 2020 $0
Revenue Q3 2021 · Sep 30, 2020 $0